A detailed history of Wakefield Asset Management Lllp transactions in Abb Vie Inc. stock. As of the latest transaction made, Wakefield Asset Management Lllp holds 11,340 shares of ABBV stock, worth $2.01 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
11,340
Previous 11,509 1.47%
Holding current value
$2.01 Million
Previous $1.97 Million 13.42%
% of portfolio
0.76%
Previous 0.72%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $27,688 - $33,686
-169 Reduced 1.47%
11,340 $2.24 Million
Q2 2024

Aug 05, 2024

SELL
$154.79 - $180.76 $773 - $903
-5 Reduced 0.04%
11,509 $1.97 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $122,741 - $139,852
768 Added 7.15%
11,514 $2.1 Million
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $1.48 Million - $1.67 Million
10,746 New
10,746 $1.67 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $330,012 - $419,554
-2,398 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $41,969 - $52,072
-318 Reduced 11.71%
2,398 $389,000
Q4 2021

Feb 01, 2022

SELL
$107.43 - $135.93 $2.19 Million - $2.77 Million
-20,352 Reduced 88.23%
2,716 $368,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $62,563 - $71,018
588 Added 2.62%
23,068 $2.49 Million
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $7,259 - $8,087
-69 Reduced 0.31%
22,480 $2.53 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $119,077 - $131,089
-1,164 Reduced 4.91%
22,549 $2.44 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $171,524 - $231,575
-2,131 Reduced 8.25%
23,713 $2.54 Million
Q3 2020

Oct 23, 2020

SELL
$85.91 - $100.83 $46,649 - $54,750
-543 Reduced 2.06%
25,844 $2.26 Million
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $154,957 - $207,356
-2,112 Reduced 7.41%
26,387 $2.59 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $1.67 Million - $2.53 Million
25,905 Added 998.65%
28,499 $2.17 Million
Q4 2019

Jan 27, 2020

BUY
$72.13 - $90.25 $187,105 - $234,108
2,594 New
2,594 $230,000
Q3 2019

Oct 25, 2019

SELL
$62.98 - $75.72 $168,597 - $202,702
-2,677 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $175,878 - $224,814
2,677 New
2,677 $195,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.